Clinical Trial Update: ARCANGELO (itAlian pRospective Study on CANGrELOr)

View source ↗

Summary

ARCANGELO is an Italian prospective study evaluating canagrelor for acute coronary syndrome; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Canagrelor (canagrelor)

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Acute Coronary Syndrome | Status: COMPLETED